Cellebrite DI Ltd

Cellebrite DI Ltd. engages in the provision of digital intelligence solutions for the law enforcement, government, and enterprise market. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cellebrite reports strong Q4 performance and eyes revenue growth

Cellebrite's Q4 performance reflects strong revenue growth, robust net retention rates, and strategic investments in key areas for future growth.
While facing challenges in currency impact and competition, the company is well-positioned to capitalize on opportunities for revenue growth acceleration and market expansion.

Cellebrite reports strong Q1 performance and focuses on digital solutions

Cellebrite's Q1 call highlighted revenue growth, strategic progress, and confidence in meeting financial targets. The company's focus on digital intelligence solutions and ethical sales practices stood out, with opportunities in AI integration and market expansion.

Cellebrite reports robust Q2 earnings, eyes growth through innovation

Cellebrite's Q2 2023 earnings call showcased strong financial performance, strategic progress, and raised outlook for 2023. The company's emphasis on innovation, customer relationships, and disciplined spending positions them for continued growth and success in the digital intelligence solutions market.

Cellebrite reports record Q3 results, eyes growth in digital forensics

Cellebrite's Q3 performance showcased strong results and growth drivers, with a focus on expanding customer relationships and innovation.
The company's strategic priorities include leadership in digital forensic units, growth in investigative units, and leveraging cloud capabilities for future success.
With a robust financial outlook, Cellebrite aims to achieve revenue targets, improve EBITDA margins, and capitalize on opportunities in both public and private sectors.

Cellebrite surpasses Q4 targets, eyes market expansion and customer success

Cellebrite's strong financial performance in Q4 2023 and strategic priorities for 2024 position the company for continued growth and market leadership.
Emphasis on customer success through training initiatives and post-sale experience enhances revenue growth and customer engagement.
Opportunities in market expansion, technology investments, and customer relationships drive Cellebrite's focus on profitability and business expansion.

Cellebrite reports robust Q1 earnings, eyes growth in digital solutions

Cellebrite's Q1 2024 performance reflects strong financial metrics and strategic focus on digital solutions. While facing challenges in transitioning to new products and sustaining margins, the company is well-positioned to capitalize on growth opportunities in the public and private sectors. By leveraging its operational efficiency and market positioning, Cellebrite aims to achieve its 2024 targets and drive future growth.

Cellebrite excels in Q2 with strong growth and strategic acquisitions

Cellebrite's Q2 performance showcased robust growth driven by key products and market expansion, with a focus on enhancing customer value through AI capabilities and strategic acquisitions.
While facing challenges in execution and market dynamics, the company's emphasis on innovation and customer success presents opportunities for sustained growth and differentiation.
Overall, Cellebrite's financial updates, strategic priorities, and partnerships position it well for continued success and value creation in the digital forensic solutions market.

Cellebrite exceeds Q3 revenue targets, CEO transition announced

Cellebrite's Q3 2024 performance showcased exceptional revenue growth, profitability, and strategic initiatives to drive future success.
While facing challenges such as CEO succession and customer adoption rates, the company is well-positioned to capitalize on opportunities in cloud investments and AI capabilities.
By focusing on customer upgrades, expanding into new sectors, and optimizing its operations, Cellebrite is poised for sustained growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

I maintain a neutral rating on Cellebrite due to its premium valuation and risks from CEO transition and potential federal budget cuts. Despite solid growth, including a 27% revenue increase and expanding margins, uncertainties around leadership and federal funding impact my outlook. Strong adoption of Inseyets, Guardian, and Pathfinder products, with notable ARR growth, suggests a long growth runway ahead.

Cellebrite: There Are Potential Risks That Could Damper Growth

Cellebrite DI Ltd. (NASDAQ:CLBT ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Andrew Kramer - Investor Relations Yossi Carmil - CEO Dana Gerner - CFO Thomas Hogan - Executive Chairman Conference Call Participants Shaul Eyal - TD Cowen Michael Cikos - Needham Jeffrey Van Rhee - Craig-Hallum Brian Essex - JP Morgan Jonathan Ho - William Blair Tomer Zilberman - Bank of America Max Michaels - Lake Street Capital Operator Welcome to the Cellebrite Third Quarter 2024 Financial Results Conference Call.

Cellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call Transcript

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share.

Cellebrite DI Ltd. (CLBT) Tops Q3 Earnings and Revenue Estimates

Third- q uarter 2024 r evenue of $106.9 million exceeds $100 million quarterly revenue milestone  for the first time in Company history

CORRECTION: Cellebrite Announces Third-Quarter 2024 Results

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024.

Yossi Carmil to Step Down as CEO After Nearly 20 Years

Cellebrite DI Ltd. (CLBT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

What Makes Cellebrite DI Ltd. (CLBT) a New Strong Buy Stock

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2024 financial results before market open on Wednesday, November 6, 2024.

Cellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024

Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?

Cellebrite DI Ltd. (CLBT) Hit a 52 Week High, Can the Run Continue?

Here is how Cellebrite DI Ltd. (CLBT) and Nexxen International Ltd.

Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?

Remote Mobile Collection enables faster device access and analysis, saving corporate investigators time and money Remote Mobile Collection enables faster device access and analysis, saving corporate investigators time and money

Cellebrite Patents its Remote Mobile Collection Capabilities for Businesses

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the results of the completed redemption (the “Redemption”) of its Warrants (as defined below) to purchase ordinary shares of the Company (the “Ordinary Shares”).

Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants

Pathfinder's capabilities are now available via the cloud,  giving law enforcement new deployment options to accelerate justice

Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the “Redemption Fair Market Value” in connection with its previously announced redemption of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”).

Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants

Cellebrite's 2Q24 results exceeded expectations with solid revenue growth and profit metrics. Progress in key metrics and initiatives indicate potential for >20% growth in the future. CLBT's Valuation has caught up, making the upside less attractive despite a positive fundamental outlook.

Cellebrite: Rating Downgrade As Valuation Has Caught Up

Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge

Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.

Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?

Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?

Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Brad Zelnick - Deutsche Bank Mike Cikos - Needham Eric Martinuzzi - Lake Street Shaul Eyal - TD Cowen Jeff Van Rhee - Craig-Hallum Brian Essex - JPMorgan Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.

Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share.

Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates

Revenue of $95.7 million, 25% year-over-year increase primarily due to 27% growth in subscription revenue; ARR of $345.9 million, up 26% year-over-year; Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin; Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR

Cellebrite Announces Second-Quarter 2024 Results

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today that it will redeem all of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”) that remain outstanding at 5:00 p.m. New York City time on September 16, 2024 (the “Redemption Date”) for a redemption price of $0.10 per Warrant.

Cellebrite Announces Redemption of All Outstanding Warrants

Seasoned Executive Brings Significant Operational and Sales Experience from Leading Technology Companies as Cellebrite Further Expands its Business Globally Seasoned Executive Brings Significant Operational and Sales Experience from Leading Technology Companies as Cellebrite Further Expands its Business Globally

Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors

Appointment of first-ever CIO underscores the Company's commitment to technological innovation to accelerate justice through the Company's Case-to-Closure platform Appointment of first-ever CIO underscores the Company's commitment to technological innovation to accelerate justice through the Company's Case-to-Closure platform

Cellebrite Appoints Renowned Cybersecurity Expert Sigalit Shavit as Chief Information Officer

Collaboration between two powerhouses will deliver innovative solutions for seamless mobile device collection, processing and review CHICAGO and TYSONS CORNER, Va. and PETAH TIKVA, Israel , July 30, 2024 /PRNewswire/ -- Relativity, a global legal technology company, and Cellebrite (Nasdaq: CLBT), a global leader in digital investigative solutions, today announced a strategic partnership that will deliver cutting-edge solutions for mobile device collection, processing and review.

News for Cellebrite DI Ltd Stock (CLBT)